NATUS MEDICAL INCORPORATED

(NTUS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Natus Medical Boosts Q4, Full-Year Revenue Outlook

01/10/2022 | 04:13pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
NATUS MEDICAL INCORPORATED 0.00% 32.67 Delayed Quote.37.67%
ON SEMICONDUCTOR CORPORATION 0.43% 56.07 Delayed Quote.-17.45%
All news about NATUS MEDICAL INCORPORATED
05/17NATUS MEDICAL INVESTOR ALERT BY THE : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
BU
05/06NATUS MEDICAL INC Management's Discussion and Analysis of Financial Condition and Resu..
AQ
05/05NATUS MEDICAL INVESTOR ALERT BY THE : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
BU
05/05NATUS MEDICAL : Q1 Earnings Snapshot
AQ
05/05Earnings Flash (NTUS) NATUS MEDICAL INCORPORATED Reports Q1 EPS $0.22, vs. Street Est o..
MT
05/05Natus Medical Q1 Non-GAAP EPS, Revenue Rise
MT
05/05Natus Medical Incorporated Reports Earnings Results for the First Quarter Ended March 3..
CI
05/05Natus Medical Announces First Quarter 2022 Financial Results
AQ
04/19CORRECTION : Sector Update: Health Care Stocks Stumble Monday Afternoon
MT
04/18SHAREHOLDER ALERT : Weiss Law Investigates Natus Medical Incorporated
PR
More news
Financials (USD)
Sales 2022 495 M - -
Net income 2022 34,0 M - -
Net Debt 2022 - - -
P/E ratio 2022 33,0x
Yield 2022 -
Capitalization 1 119 M 1 119 M -
Capi. / Sales 2022 2,26x
Capi. / Sales 2023 2,16x
Nbr of Employees 1 400
Free-Float 98,1%
Chart NATUS MEDICAL INCORPORATED
Duration : Period :
Natus Medical Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NATUS MEDICAL INCORPORATED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 32,67
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Thomas J. Sullivan President, Chief Executive Officer & Director
Benjamin Drew Davies Chief Financial Officer & Executive Vice President
Joshua H. Levine Non-Executive Chairman
Ivan Pandiyan Senior Director-Research & Development
Seán Langan Vice President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
NATUS MEDICAL INCORPORATED37.67%1 119
THERMO FISHER SCIENTIFIC-18.74%212 239
DANAHER CORPORATION-24.22%174 392
INTUITIVE SURGICAL, INC.-39.29%77 301
SIEMENS HEALTHINEERS AG-17.17%65 558
EDWARDS LIFESCIENCES CORPORATION-27.16%58 078